These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31106972)

  • 1. A Link Between Plasma Microbial Translocation, Microbiome, and Autoantibody Development in First-Degree Relatives of Systemic Lupus Erythematosus Patients.
    Ogunrinde E; Zhou Z; Luo Z; Alekseyenko A; Li QZ; Macedo D; Kamen DL; Oates JC; Gilkeson GS; Jiang W
    Arthritis Rheumatol; 2019 Nov; 71(11):1858-1868. PubMed ID: 31106972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls.
    Young KA; Terrell DR; Guthridge JM; Kamen DL; Gilkeson GS; Karp DR; Ishimori ML; Weisman MH; Holers VM; Harley JB; Norris JM; James JA
    Lupus; 2014 Apr; 23(4):360-9. PubMed ID: 24449338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct systemic microbiome and microbial translocation are associated with plasma level of anti-CD4 autoantibody in HIV infection.
    Xu W; Luo Z; Alekseyenko AV; Martin L; Wan Z; Ling B; Qin Z; Heath SL; Maas K; Cong X; Jiang W
    Sci Rep; 2018 Aug; 8(1):12863. PubMed ID: 30150778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members.
    Bruner BF; Guthridge JM; Lu R; Vidal G; Kelly JA; Robertson JM; Kamen DL; Gilkeson GS; Neas BR; Reichlin M; Scofield RH; Harley JB; James JA
    Arthritis Rheum; 2012 Nov; 64(11):3677-86. PubMed ID: 23112091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients.
    Syahidatulamali CS; Wan Syamimee WG; Azwany YN; Wong KK; Che Maraina CH
    J Postgrad Med; 2017; 63(4):257-261. PubMed ID: 28862243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA.
    Becker Y; Marcoux G; Allaeys I; Julien AS; Loignon RC; Benk-Fortin H; Rollet-Labelle E; Rauch J; Fortin PR; Boilard E
    Front Immunol; 2019; 10():1026. PubMed ID: 31134086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG and IgM autoantibody differences in discoid and systemic lupus patients.
    Chong BF; Tseng LC; Lee T; Vasquez R; Li QZ; Zhang S; Karp DR; Olsen NJ; Mohan C
    J Invest Dermatol; 2012 Dec; 132(12):2770-9. PubMed ID: 22763789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes.
    Li QZ; Zhou J; Wandstrat AE; Carr-Johnson F; Branch V; Karp DR; Mohan C; Wakeland EK; Olsen NJ
    Clin Exp Immunol; 2007 Jan; 147(1):60-70. PubMed ID: 17177964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Distinct Plasma Microbiome But Not Gut Microbiome in Patients With Systemic Lupus Erythematosus Compared to Healthy Individuals.
    James WA; Ogunrinde E; Wan Z; Kamen DL; Oates J; Gilkeson GS; Jiang W
    J Rheumatol; 2022 Jun; 49(6):592-597. PubMed ID: 35169056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies persist in relatives to systemic lupus erythematosus patients during 12 years follow-up.
    Langkilde H; Voss A; Heegaard N; Laustrup H
    Lupus; 2017 Jun; 26(7):723-728. PubMed ID: 27831535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial Differences in Plasma Microbial Translocation and Plasma Microbiome, Implications in Systemic Lupus Erythematosus Disease Pathogenesis.
    Wen X; Ogunrinde E; Wan Z; Cunningham M; Gilkeson G; Jiang W
    ACR Open Rheumatol; 2024 Jun; 6(6):365-374. PubMed ID: 38563441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens.
    van der Linden MW; Westendorp RG; Zidane M; Meheus L; Huizinga TW
    J Rheumatol; 2001 Feb; 28(2):284-7. PubMed ID: 11246662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives.
    Steup-Beekman G; Steens S; van Buchem M; Huizinga T
    Lupus; 2007; 16(5):329-34. PubMed ID: 17576734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
    Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
    Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
    Doe K; Nozawa K; Hiruma K; Yamada Y; Matsuki Y; Nakano S; Ogasawara M; Nakano H; Ikeda T; Ikegami T; Fujishiro M; Kawasaki M; Ikeda K; Amano H; Morimoto S; Ogawa H; Takamori K; Sekigawa I; Takasaki Y
    Lupus; 2014 Sep; 23(10):1031-41. PubMed ID: 24836587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus.
    Sohrabian A; Parodis I; Carlströmer-Berthén N; Frodlund M; Jönsen A; Zickert A; Sjöwall C; Bengtsson AA; Gunnarsson I; Rönnelid J
    Arthritis Res Ther; 2019 Nov; 21(1):259. PubMed ID: 31783909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE.
    Ahlin E; Mathsson L; Eloranta ML; Jonsdottir T; Gunnarsson I; Rönnblom L; Rönnelid J
    Lupus; 2012 May; 21(6):586-95. PubMed ID: 22300829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent Bacteriuria and Antibodies Recognizing Curli/eDNA Complexes From Escherichia coli Are Linked to Flares in Systemic Lupus Erythematosus.
    Pachucki RJ; Corradetti C; Kohler L; Ghadiali J; Gallo PM; Nicastro L; Tursi SA; Gallucci S; Tükel Ç; Caricchio R
    Arthritis Rheumatol; 2020 Nov; 72(11):1872-1881. PubMed ID: 32840064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.